GenetiSure Cancer Research CGH+SNP Microarray (2x400K)
The GenetiSure Cancer Research CGH+SNP microarray is designed to target cancer regions of the genome sourced from the COSMIC and CGC databases. Loss of heterozygosity (LOH) detection, with a resolution validated to 2.5 MB, ensures that important aberrations are not missed.
The Agilent CGH+SNP technology features exon-targeted probe content that allows for faster, more efficient association of aberrations with disease phenotypes. 89% of the exon is covered in the process. The CGC cancer array is optimized for CGH (comparative genomic hybridization) and CGH+SNP (Loss of heterozygosity) microarray workflows.
For Research Use Only. Not for use in diagnostic procedures.